CONQUERING CONGENITAL HEART DISEASE (EIN 463576700) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

Carissa Ostrom

Phone

8507979354

Tax Period

2023-01-01 to 2023-12-31

CONQUERING CONGENITAL HEART DISEASE, founded in 2013, is a small nonprofit in the Medical Research sector that reported $292K in total revenue in fiscal year 2023. Revenue fell 55% from the prior year — a significant decline worth monitoring. Expenses of $334K exceeded revenue, resulting in a 14% operating deficit.

Mission

CONQUERING CHD EXISTS TO CONQUER THE MOST COMMON BIRTH DEFECT. WE ENGAGE, LISTEN, LEARN AND ACT. WE CREATE VISIBILITY AND EMPOWER ALL IMPACTED BY CHD. WE ACCOMPLISH THIS THROUGH AWARENESS, KNOWLEDGE, COMMUNITY AND RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $250,821

Program Service Revenue $41,136

Investment Income $0

Other Revenue $0

TOTAL REVENUE $291,957

Expense Breakdown

Grants Paid $0

Salaries & Benefits $142,696

Fundraising Expenses $0

Program Expenses $75,866

Other Expenses $191,299

TOTAL EXPENSES $333,995

Year-over-Year Comparison

	2023	2022	Change
Revenue	$291,957	$645,405	-0.5%
Expenses	$333,995	$627,460	-0.5%
Net Income	$-42,038	$17,945	-3.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$86,113

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Mark Fried	Former Executive Director	40.00	Officer	$16,797	$0	$16,797
Amy Basken	Former Executive Director	40.00	Officer	$38,461	$0	$38,461
Carissa Ostrom	Executive Director	40.00	Officer	$30,855	$0	$30,855
Melissa Stevens	Director	1.00		$0	$0	$0
Tom Eby	Director	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$291,957	$333,995	$21,394	$-42,038
2022	$645,405	$629,601	$116,383	$15,804
2021	$581,914	$696,586	$163,592	$-114,672
2020	$608,854	$774,316	$265,513	$-165,462
2019	$728,502	$666,658	$394,288	$61,844
2018	$529,138	$297,176	$319,182	$231,962

CONQUERING CONGENITAL HEART DISEASE